A consistent finding across studies is that A20 expression is significantly downregulated in the immune cells of SLE patients, an insufficiency that correlates inversely with disease activity indices and the development of lupus nephritis [321]. The gene discussed is TNFAIP3; the disease is systemic lupus erythematosus.